Hurvitz, S. A., Saura, C., Oliveira, M., Trudeau, M. E., Moy, B., Delaloge, S., Gradishar, W., Kim, S., Haley, B., Ryvo, L., Dai, M., Milovanov, V., Alarcón, J., Kalmadi, S., Cronemberger, E., Souza, C., Landeiro, L., Bose, R., Bebchuk, J., Kabbinavar, F., Bryce, R., Keyvanjah, K., & Brufsky, A. M. (2021). efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial. Oncologist, 26, e1327–e1338. http://access.bl.uk/ark:/81055/vdc_100139608730.0x000032